INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs
Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
-
Isolators For Pharmacy Compounding – Time For Change?
Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.
-
De-Risking The Transition From Vial To Drug-Device Combination Product
When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.
-
Host Cell Impurities, Bioassays, Micro-Flow Imaging
Ensuring the safety and efficacy of cutting-edge biopharmaceuticals hinges on meticulous quality control measures. Explore the role of qPCR and MFI in safeguarding drugs from potential contamination.
-
Still Pipette-Filling Cryovials? There's A Better Way7/7/2025
Manual cryovial filling in cell therapy is risky, time-consuming, and unsustainable. Learn why automating this crucial step is essential for precision, viability, and scalability.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics11/7/2025
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
-
Filling Syringes With Spray-Dried Powders - The How, The Why And The Benefits11/3/2025
Discover how filling spray-dried powders directly into syringes improves stability, minimizes cold chain reliance, and accelerates administration speeds for critical therapies.
-
Maintaining Sterility Through Precise Component Design And Manufacture2/4/2026
Prioritizing high-quality component design and manufacturing excellence can mitigate risks, ensure long-term container closure integrity, and avoid the costly delays associated with non-compliance.
-
Finding The Right Aseptic Processing Approach8/28/2024
How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Used 200 liter Feldmeier reactor, 316L stainless steel construction, approximately 26" diameter x 25" straight side, removable dish top, dish bottom, rated 60 psi and full vacuum at 302 f internal, jacketed for 125 psi and full vacuum at 353 f, .75 hp bottom mounted agitator drive, 230/460 volt, serial# SO29512, national board# 4463, built 2012.
-
AST’s ASEPTiCell® and GENiSYS® systems combine industry-proven technologies such as robotics and isolator-barrier systems to provide flexible pharmaceutical aseptic filling and closing of ready-to-use vials, syringes, and cartridges with a single machine. These innovative platforms use a modular design approach to provide a truly adaptive system with the capabilities and features necessary for cGMP production of clinical and commercial sterile injectable products.
-
Used IMA cartoner, model IC150C, speeds up to 120 cartoners/minute, designed for pre glued cartons, 28 mm wide x 12 mm high x 55 mm long minimum carton size, 92 mm wide x 60 mm high x 190 mm long maximum carton size, with blister feeder, with leaflet inserter, Allen Bradley Micrologix 1500 plc with Panelview 550 HMI, Machine# B-92-024, built 2005.
-
Accelerate single-cell and low-volume workflows with high precision, fast setup, and surfactant-free dispensing that delivers reproducible results and flexible performance across cell types and reagents.
-
BD Physioject™ Disposable Autoinjector offers a proven, user-friendly platform for self-injection, enhancing patient comfort, safety, and adherence across multiple chronic disease treatments globally.